InvestorsHub Logo

Roofus

05/09/23 12:22 PM

#161416 RE: SC8 #161410

They’ve added no more than 10% dilution in two years.

I’m not worried.
Bullish
Bullish

chereb19

05/09/23 12:32 PM

#161418 RE: SC8 #161410

What do you think the FDA are doing every time Vivos walk into a pre-sub meeting with the Mayo clinic reps at their side. Yes that's right. REVIEW.

Don't believe me, believe the FDA's own written comments

The EFS Program provides a mechanism for innovators to work directly with sponsors, FDA review teams, and clinicians to collaborate early so they can increase the efficiency of their device development. Early clinical experience obtained from an EFS can provide insights for sponsors and FDA review teams into issues such as device proof of concept, patient characteristics that may impact performance, operator technique refinements, device safety, necessary device modifications, and human factors.